Antibiotics and antibiotic resistance

-Automatic translation

Broad-spectrum beta-lactamase-producing pathogens are diseases subject to registration by the Chief Epidemiologist. Diseases subject to registration can threaten public health.

When such an infection is suspected or confirmed, directors of laboratories shall promptly send information to the Chief Epidemiologist by further instructions.

-Automatic translation

Prevention and measures against methicillin-resistant Staphylococcus aureus (MRSA)

Methicillin-resistant Staphylococcus aureus (MRSA) has spread widely around the world, causing infections that can be difficult to treat and leading to increased costs within the healthcare system. Much has been done to stop their spread in the Nordic countries and the Netherlands, and the frequency of mosses has been lower in these countries than in other countries.
In collaboration with the Department of Infection Control and the Department of Bacteriology and Virology of Landspitali, the Chief Epidemiologist has published guidelines on "Screening, infection tracking, and infection prevention due to antibiotic-resistant bacteria in health care". Representatives from working groups from long-term care facilities and health care have also read and commented. The guidelines are written to coordinate actions against moss nationally and to reduce its spread within the health services in Iceland.

MRSA is a disease subject to registration by the Chief Epidemiologist. When such an infection is suspected or confirmed, directors of laboratories shall send information to the Chief Epidemiologist by further instructions.

-Automatic translation

Vancomycin-resistant enterococci is a disease subject to registration by the Chief Epidemiologist. When they are suspected or confirmed, directors of laboratories shall send information to the Chief Epidemiologist by further instructions.